• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    a syringe adapter includes a housing, a cannula having a first end and a second end with the second end of the cannula positioned within the housing and a clamp having a first end and a second end with at least a portion of the clamp fixation received inside the housing. the clamp includes a body defining a passage with a membrane received by the passage. the clamp includes a locking member connected to the clamp body. the membrane includes a body having a first end and a second end with the movable clamp from a first position in which the locking member is opened to receive a matching connector for a second position in which the movement radially outwardly from the member locking is restricted. the passage of the clamping body includes a narrowed portion configured to compress a portion of the membrane body.
    公开号:BR112019014626A2
    申请号:R112019014626
    申请日:2018-01-15
    公开日:2020-04-14
    发明作者:Sanders Laurie
    申请人:Becton Dickinson & Co Ltd；
    IPC主号:
    专利说明:

    “SYRINGE ADAPTER FOR CLOSED FLUID TRANSFER”
    CROSS REFERENCE TO RELATED APPLICATION [0001] This order claims priority for Provisional Order Serial No. US 62 / 447,038, filed on January 17, 2017, which is incorporated into this document as a reference in its entirety.
    BACKGROUND OF THE INVENTION
    Field of Revelation [0002] The present revelation refers, in general, to a system for the closed transfer of fluids. More particularly, the present disclosure relates to a system that provides leak-proof sealing during transfer of fluid from a first container to a second container.
    Description of Related Art [0003] Healthcare providers that reconstitute, transport and administer hazardous drugs, such as cancer treatments, can place healthcare providers at risk of exposure to these drugs and pose a major danger to the healthcare environment. For example, nurses who treat cancer patients are at risk of being exposed to chemotherapy drugs and their toxic effects. Exposure to unintended chemotherapy can affect the nervous system, damage the reproductive system and bring an increased risk of developing blood cancers in the future. In order to reduce the risk of healthcare providers being exposed to toxic drugs, the closed transfer of these drugs becomes important.
    [0004] Some drugs need to be dissolved or diluted before they are administered, which involves transferring a solvent from a container to a sealed bottle containing the drug in powder or liquid form, through a needle. Drugs can be released
    Petition 870190077185, of 08/09/2019, p. 6/41
    2/20 inadvertently in the atmosphere in the form of gas or through the formation of aerosols, during the removal of the needle from the vial and while the needle is inside the vial if any differential pressure between the inside of the vial and the surrounding atmosphere exists.
    SUMMARY OF THE INVENTION [0005] In one aspect, a syringe adapter includes a housing that has a first end and a second end, where the first end is configured to be attached to a first container, a cannula that has a first end and a second end, in which the second end of the cannula is positioned within the housing, and a clamp which has a first end and a second end, in which at least a portion of the clamp is received within the housing. The clamp includes a body defining a passage with a membrane received by the passage. The clamp includes a locking member connected to the clamp body. The membrane includes a body having a first end and a second end with the movable clamp from a first position in which the locking member is opened to receive a corresponding connector for a second position in which the movement radially outwardly from the member of locking is restricted. The passage of the clamping body includes a narrowed portion configured to compress a portion of the membrane body.
    [0006] The passage of the clamping body can comprise a first reamer, a second reamer positioned opposite the first reamer and an intermediate portion, wherein the intermediate portion of the passage of the clamping body includes the narrowed portion. The passage may be smaller in diameter than a remaining portion of the intermediate portion of the passage. The membrane may comprise a first head portion and a second head portion, wherein the first and second head portions extend radially outwardly from the body of the
    Petition 870190077185, of 08/09/2019, p. 7/41
    3/20 membrane, and the membrane body has a first portion that has a first diameter and a second portion that has a second diameter. The first diameter can be smaller than the second diameter. The intermediate portion of the passage of the body of the clamp can receive the first portion of the membrane. The second countersink in the passage of the clamping body can receive the second portion of the membrane.
    [0007] The membrane body can define a passage that can extend from the first end of the membrane body towards the second end of the membrane body. The passage of the membrane can end in an intermediate position at the first and second ends of the membrane body.
    [0008] The membrane can include a first head portion and a second head portion. The first head portion of the membrane can be positioned within the clamp passage, where the second head portion is engaged with one end of the clamp body. The first head portion may include a frustoconical surface. The second head portion may include a convex surface. The first head portion of the membrane can engage the clamp and can be positioned inside the first countersink.
    [0009] The clamp passage may have a first portion and a second portion, the first portion of the passage including the narrowed portion. The first portion of the clamp passage may have a smaller diameter than the second portion of the clamp passage.
    BRIEF DESCRIPTION OF THE DRAWINGS [0010] The features and advantages mentioned above in addition to others of this revelation, and the way to achieve them, will become more evident and the revelation itself will be better understood with reference to the following descriptions of aspects of the revelation taken together with the accompanying drawings, where:
    Petition 870190077185, of 08/09/2019, p. 8/41
    4/20 [0011] FIG. 1 is a cross-sectional view of a syringe adapter according to an aspect of the present invention.
    [0012] FIG. 2 is a cross-sectional view of a syringe adapter according to an aspect of the present invention.
    [0013] FIG. 3 is a perspective view of a clamp according to an aspect of the present invention.
    [0014] FIG.
    clamp of FIG. 3.
    [0015] FIG.
    the closed transfer of inventive fluids.
    [0016] FIG.
    system of FIG. 5.
    [0017] FIG.
    is a cross-sectional view of is a front view of a system according to one aspect of this is a cross-sectional view of
    7A is a front view of a first membrane according to an aspect of the present invention.
    [0018] FIG. 7B is a cross-sectional view of the first membrane of FIG. 7A.
    [0019] FIG. 8A is a front view of a first membrane according to an aspect of the present invention.
    [0020] FIG. 8B is a cross-sectional view of the first membrane of FIG. 8A.
    [0021] FIG. 9A is a front view of a first membrane according to an aspect of the present invention.
    [0022] FIG. 9B is a cross-sectional view of the first membrane of FIG. 9A.
    [0023] FIG. 10A is a front view of a first membrane according to an aspect of the present invention.
    [0024] FIG. 10B is a cross-sectional view of the first membrane of FIG. 10A.
    [0025] FIG. 11A is a front view of a first
    Petition 870190077185, of 08/09/2019, p. 9/41
    5/20 membrane according to an aspect of the present invention.
    [0026] FIG. 11B is a cross-sectional view of the first membrane of FIG. 11 A.
    [0027] FIG. 12A is a front view of a first membrane according to an aspect of the present invention.
    [0028] FIG. 12B is a cross-sectional view of the first membrane of FIG. 12A.
    [0029] FIG. 13A is a front view of a first membrane according to an aspect of the present invention.
    [0030] FIG. 13B is a cross-sectional view of the first membrane of FIG. 13A.
    [0031] FIG. 14Ais a front view of a second membrane according to an aspect of the present invention.
    [0032] FIG. 14B is a cross-sectional view of the second membrane of FIG. 14A.
    [0033] FIG. 15A is a front view of a second membrane according to an aspect of the present invention.
    [0034] FIG. 15B is a cross-sectional view of the second membrane of FIG. 15A.
    [0035] FIG. 16A is a front view of a second membrane according to an aspect of the present invention.
    [0036] FIG. 16B is a cross-sectional view of the second membrane of FIG. 16A.
    [0037] FIG. 17A is a front view of a second membrane according to an aspect of the present invention.
    [0038] FIG. 17B is a cross-sectional view of the second membrane of FIG. 17A.
    [0039] FIG. 18A is a front view of a second membrane according to an aspect of the present invention.
    [0040] FIG. 18B is a cross-sectional view of the
    Petition 870190077185, of 08/09/2019, p. 10/41
    6/20 second membrane of FIG. 18A.
    [0041] FIG. 19A is a front view of a second membrane according to an aspect of the present invention.
    [0042] FIG. 19B is a cross-sectional view of the second membrane of FIG. 19A.
    [0043] FIG. 20 is a front view of a system for the closed transfer of fluids according to an aspect of the present invention.
    [0044] FIG. 21 is a cross-sectional view of the system shown in FIG. 20.
    [0045] FIG. 22 is a cross-sectional view of a syringe adapter according to an aspect of the present invention.
    [0046] FIG. 23 is a cross-sectional view of a syringe adapter according to an aspect of the present invention.
    [0047] FIG. 24 is a front view of a syringe adapter in accordance with an aspect of the present invention.
    [0048] FIG. 25 is a front view of a system for closed fluid transfer in accordance with an aspect of the present invention.
    [0049] FIG. 26 is a cross-sectional view of the system of FIG. 25.
    [0050] FIG. 27 is a cross-sectional view of the system of FIG. 25 showing a patient connector attached to a syringe adapter.
    [0051] FIG. 28 is a top view of the patient connector of FIG. 25 according to an aspect of the present invention.
    [0052] FIG. 29 is an enlarged cross-sectional view of the system of FIG. 25 showing a patient connector attached to a syringe adapter.
    [0053] FIG. 30 is a perspective view of a
    Petition 870190077185, of 08/09/2019, p. 11/41
    7/20 closed fluid transfer system according to an aspect of the present invention.
    [0054] FIG. 31 is a cross-sectional view of the system of FIG. 30.
    [0055] FIG. 32 is a cross-sectional view of the system of FIG. 30 showing a patient connector attached to a syringe adapter with a locking mechanism in an unlocked position.
    [0056] FIG. 33 is a perspective view of the system of FIG. 30 showing a patient connector attached to a syringe adapter with a locking mechanism in a locked position.
    [0057] FIG. 34 is a cross-sectional view of the system of FIG. 30 showing a patient connector attached to a syringe adapter with a locking mechanism in a locked position.
    [0058] FIG. 35 is an exploded perspective view of the system of FIG. 30 according to one aspect of the present invention.
    [0059] The corresponding reference characters indicate corresponding parts across all the countless views. The exemplifications presented in this document illustrate exemplary aspects of the disclosure and such exemplifications should not be construed as limiting the scope of the disclosure in any way.
    DETAILED DESCRIPTION [0060] The following description is provided to allow elements skilled in the art to carry out and use the described aspects contemplated to carry out the invention. Several modifications, equivalents, variations and alternatives, however, will remain readily evident to the elements skilled in the art. Any and all such modifications, variations, equivalents and alternatives are intended to be included in the spirit and scope of the present invention.
    [0061] For the purposes of the description hereinafter
    Petition 870190077185, of 08/09/2019, p. 12/41
    8/20 this document, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives they must refer to the invention as outlined in the attached figures. However, it should be understood that the invention may take several alternative variations, except when expressly stated to the contrary. It should also be understood that the specific devices illustrated in the accompanying drawings and described in the following specification are simply exemplary aspects of the invention. Thus, the specific dimensions and other physical characteristics related to the aspects revealed in this document should not be considered as limiting.
    [0062] With reference to FIG. 1, a syringe adapter 12 according to an aspect of the present invention is shown. Syringe adapter 12 is a component of a system for closed fluid transfer. In particular, syringe adapter 12 is configured to connect a syringe (not shown) to another medical device or fluid container. The medical device can be, for example, a patient line, a bottle adapter, a fluid container or an infusion adapter. In other examples, the container may be a medical bottle, a syringe barrel, an IV pouch or a similar container for holding a fluid to be administered to a patient. The syringe adapter 12 can be used to facilitate the closed transfer of fluids between the syringe and the medical device or fluid container. The syringe adapter 12 is similar to and operates in a similar manner as the syringe adapter shown and described in Patent Application Publication No. US 2015/0297454, which is incorporated herein by reference in its entirety for reference.
    [0063] With reference again to FIG. 1, the syringe adapter 12 includes a housing 16 having a first end 18 and a second end 20 and defining an interior space
    22. The first end 18 of the housing 16 of the syringe adapter 12 includes a syringe holder 24, such as a female type luer connector, which
    Petition 870190077185, of 08/09/2019, p. 13/41
    9/20 defines a passage 26. Although a female type luer connector is shown for connection to a corresponding male syringe type luer connector (not shown), other suitable connection arrangements can be used for connection to a syringe , a container or any other medical device. A cannula 28 having a distal end 30 is attached to the syringe fixture 24 and is in fluid communication with the passage 26 of the syringe fixture 24. The syringe adapter 12 additionally includes a sealing arrangement positioned within the housing 16 of the syringe adapter. syringe 12. The sealing arrangement includes a clamp 32 that receives a first membrane 34. The clamp 32 is configured to move within the inner space 22 of housing 16 of syringe adapter 12 as discussed in more detail below. The housing 16 of the syringe adapter 12 may include structure to enhance the grip of the syringe adapter 12 by a user. Additional or alternative handle structures and surfaces can be provided to assist a user in grasping the body of the syringe adapter 12.
    [0064] The syringe adapter 12 includes a first connection interface 36 positioned intermediate to the first and second ends 18, 20 of the housing 16 of the syringe adapter 12 which includes a locking member 38 which is received within a transverse opening 40 in housing 16 of the syringe adapter 12. Locking member 38 is configured to move between a closed position and an open position. The locking member 38 additionally includes a cantilever spring 46 that extends in a longitudinal direction of the syringe adapter 12. The locking member 38 is configured to engage a cam surface that extends radially outwardly from housing 16 of the syringe adapter 12. In particular, the locking member 38 is configured to be supplied in the closed position, where a portion of the locking member 38 is adjacent to a central opening of the locking member 38 is positioned within the interior space 22 of the syringe adapter 12 when no external force is applied to the locking member 38. When the
    Petition 870190077185, of 08/09/2019, p. 14/41
    10/20 lock 38 is moved to the open position where the central opening of locking member 38 is aligned with the inner space 22 of the syringe adapter 12 or does not create an interference or barrier to objects that are inserted into the inner space 22, in that the cantilever spring 46 engages the meat surface to create a polarizing force that stimulates the locking member 38 back towards the closed position. Consequently, when the locking member 38 is moved to the open position, the locking member 38 will be stimulated back to the closed position when the external force acting on the locking member 38 is released. Although the locking member 38 is shown with the cantilever spring 46, any other member of suitable inclination can be provided, including, but not limited to, compression springs, extension springs, elastomeric material, etc.
    [0065] With reference to FIGS. 1 and 3, the clamp 32 has a body 52 with a first end 54 and a second end 56. The body 52 defines a passage 58 that extends through the body 52. The body 52 is generally cylindrical, although other clamps of suitable format can be used. The clamp 32 additionally includes a locking member 60 connected to the body 52 of the clamp 32. The clamp 32 is movable from a first position where the locking member 60 is open to receive a corresponding connector, such as a patient connector, for a second position in which movement radially out of the locking member 60 is restricted. The locking member 60 is connected to the body 52 by means of a plurality of arms 62. The locking member 60 is arched and resistant as a result of connecting the locking member 60 to the body 52 by means of the plurality of arms 62. More specifically, the plurality of arms 62 is flexible and allows the locking member 60 to expand radially outward or radially inward. In one aspect, locking member 60 is configured to expand radially outward when a corresponding connector, such as a patient connector, is inserted into the
    Petition 870190077185, of 08/09/2019, p. 15/41
    11/20 locking 60 and subsequently moves radially inward as the clamp 32 is moved from the first position to the second position. Alternatively, the locking member 60 may not move radially inward or outward when a corresponding connector is inserted into the locking member 60 and may subsequently move radially inward as the clamp 32 is moved from the first position to the second position. The second end 20 of the housing 16 of the syringe adapter 12 defines an annular indentation 64 adjacent the interior space 22 which receives the locking member 60 when the clamp 32 is in the first position. The annular recess 64 of the housing 16 provides space for the locking member 60 to expand radially outwardly. When the clamp 32 is moved from the first position to the second position, where the clamp 32 moves axially towards the first end 18 of the syringe adapter 12, where the locking member 60 is polarized inwardly polarized due to the engagement of the locking member 60 with the housing 16 of the syringe adapter 12.
    [0066] As shown in FIG. 3, the locking member 60 of the clamp 32 defines a pair of openings 66 that extends in a direction perpendicular to a longitudinal geometric axis of the clamp 32. The openings 66 forks the locking member 60 in two arcuate portions that they are each connected to the body 52 of the clamp 32 by two arms 62. However, other suitable arrangements and shapes for the clamp 32 and the locking member 60 can be used. The locking member 60 of the clamp 32 protrudes radially inward and radially outwardly with respect to the plurality of arms 62.
    [0067] With reference again to FIGS. 1 and 3, the body 52 of the clamp 32 includes a second connection interface 70 which is configured to match and lock with the first connection interface 36 of the syringe adapter 12. The second connection interface 70 is defined
    Petition 870190077185, of 08/09/2019, p. 16/41
    12/20 by the body 52 of the clamp 32. The first end 54 of the clamp 32 is configured to be received inside the inner space 22 of the syringe adapter 12 when the locking member 38 of the first connection interface 36 is in the open position and cannot move within the inner space 22 of the syringe adapter 12 when the locking member 38 is in the closed position. When the second connection interface 70 corresponds completely with the first connection interface 36, the locking member 38 of the first connection interface 36 is configured to be in the closed position to lock the first connection interface 36 with longitudinal and transverse movement relative to the second connection interface 70, but still allowing rotary movement in relation to it.
    [0068] With reference to FIG. 1, the passage 58 of the body 52 of the clamp 32 includes a first countersink 68, a second countersink 74, positioned opposite the first countersink 68, and an intermediate portion 76 positioned between the first and second countersinks 68, 74.
    [0069] With reference to FIG. 3, the clamp body 32 also includes a plurality of ribs 78 positioned intermediate to the first end 54 and the second end 56. The ribs 78 extend longitudinally, although other suitable configurations can be used. A plurality of recesses 80 are positioned between adjacent ribs 78.
    [0070] With reference to FIGS. 2 to 6, in one aspect of the present invention, passage 58 of the clamp body 32 includes a narrowed portion 79 configured to compress a portion of the first membrane 34. In one aspect, the intermediate portion 76 of passage 58 of body 52 of the clamp 32 includes the narrowed portion 79. The narrowed portion 79 of passage 58 has a smaller diameter than a remaining portion of the intermediate portion 76 of passage 58.
    [0071] With reference to FIGS. 2 and 6, the first membrane 34 includes a body 82 which has a first end 84 and a
    Petition 870190077185, of 08/09/2019, p. 17/41
    Second end 86. The first end 84 and the second end of the body 82 of the first membrane 34 include a first head portion 88 and a second head portion 90, respectively. The body 82 of the first membrane 34 defines a passage 92 extending from the first end 84 towards the second end 86 of the body 82. The passage 92 ends in an intermediate position with the first and second ends 84, 86 of the body 82. The body 82 of the first membrane 34 also defines an annular recessed portion 87 positioned intermediate to the first and second ends 84, 86. body 82 of the first membrane 34 is received by the passage 58 of the clamp 32 and is attached to the clamp 32 The first head portion 88 of the first membrane 34 engages the first countersink 68 of the clamp 32. The second head portion 90 extends beyond the passage 58 of the body 52 of the clamp 32, where the second head portion 90 engages the body 52 of the clamp 32. The annular recessed portion of the first member 34 is received by the intermediate portion 76 of the clamp 32, where the narrowed portion 79 engages and compresses the annular recessed portion 87 of the first member 34.
    [0072] The second head portion 90 defines a convex surface, although other suitable membrane arrangements can be provided as discussed in more detail below. The cannula 28 is received into the pass 92 of the first membrane 34 with the distal end 30 of the cannula 28 positioned inside the pass 92 when the clamp 32 is in the first position. The distal end 30 of the cannula 28 is configured to pierce the first membrane 34 and extend through the first membrane 34 when the clamp 32 is transitioned from the first position to the second position. The first membrane 34 is configured to engage and seal an intermediate portion of the cannula 28 while using the syringe adapter 12 to maintain a leak-free, sealed connection with a matching component.
    [0073] By engaging the first membrane 34
    Petition 870190077185, of 08/09/2019, p. 18/41
    14/20 by a corresponding membrane during use, such as a second membrane 94 of patient connector 96, a bottle adapter or IV bag with spout, the clamp 32 is configured to move towards the first end 18 of the adapter syringe 12 and transition from the first position to the second position so that the distal end 30 of the cannula 28 punctures the first membrane 34 to place the syringe adapter 12 in fluid communication with corresponding devices attached to the syringe adapter 12. When the clamp fixation 32 is returned to the first position, the first membrane 34 can be disengaged from the corresponding membrane, thus positioning the distal end 30 of the cannula 28 within the passages 58, 92 of the fixation clamp 32 and the first membrane 34. Such This arrangement protects the distal end 30 of the cannula 28 to prevent accidental needle sticks and also prevents any fluid from leaking during transfusion. fluids when using the syringe adapter 12.
    [0074] With reference to FIGS. 5 and 6, patient connector 96 includes a body 102 that has a first end 104 and a second end 106 and defines a passage 108 that extends therethrough. The first end 104 of the patient connector 96 also includes a clamp interface 110. The clamp interface 110 is defined by a portion of the body 102 of the patient connector 96 that is recessed from the first end 104 of the body 102 of patient connector 96. The first end 104 of body 102 of patient connector 96 also includes a membrane seat 112 that receives a second membrane 94. As discussed above in connection with syringe adapter 12, the second membrane 94 of the patient connector 96 is configured to engage the first membrane 34 of syringe adapter 12 and provide a substantially leak-free connection to syringe adapter 12 during fluid transfer. The second end 106 of patient connector 96 includes an IV line attachment, such as a male type luer connector, although any other suitable connection arrangement can be
    Petition 870190077185, of 08/09/2019, p. 19/41
    15/20 used.
    [0075] With reference to FIGS. 2 and 6, as discussed above, the narrowed portion 79 of the body passage 52 of the clamp 32 compresses the first membrane 34. In particular, the narrowed portion 79 compresses the annular indented portion 89 of the first membrane 34. During use of the syringe adapter 10, back pressure acting on the first membrane 34 can potentially disassemble the first membrane 34 of the clamp 32. The narrowed portion 79 acts as a back pressure resistance feature by applying additional compression between the clamp 32 and the first membrane 34.
    [0076] With reference to FIGS. 7A to 13B, additional aspects of the first membrane 34 are shown. In particular, several shapes, configurations and cavities can be used for the first membrane 34. The geometries shown in FIGS. 7A to 13B can be pushed or pulled on a matching component and retained without the need for secondary assembly processes or multi-piece housings. Passage 92 of the first membrane can include various shapes, lengths, widths and configurations. Additionally, as shown in FIGS. 12 to 13B, the first end 84 of the first membrane 34 may not include a head portion or radial projections.
    [0077] With reference to FIGS. 14A to 19B, additional aspects of the second membrane 94 are shown. In particular, several shapes and configurations can be used for the second membrane 94. As shown in FIGS. 17A and 17B, the second membrane 94 can include an annular recess 98.
    [0078] With reference to FIGS. 21 to 24, a syringe adapter 120 and patient connector 122, according to a further aspect of the present invention, are shown. The syringe adapter 120 is similar to the syringe adapter 12 shown in FIG. 1 and operates in a similar way. Syringe adapter 120 and patient connector
    Petition 870190077185, of 08/09/2019, p. 20/41
    16/20
    122 of FIGS. 21 to 24, however, include a different connection arrangement. In particular, instead of providing the first and second connection interfaces 36, 70, patient connector 122 includes a locking mechanism 124 that has a tilt member 126 and an engagement member 128 positioned on the tilt member 126. Coupling member 128 is configured to engage a portion of housing 16 of syringe adapter 120 to secure patient connector 122 to syringe adapter 120 when patient connector 122 is received by syringe adapter 120. Although the locking mechanism 124 is shown in connection with patient connector 122, locking mechanism 124 can be provided in any suitable component of a closed fluid transfer system, including, but not limited to, bottle adapters, infusion adapters, etc.
    [0079] The tilting member 126 of the locking mechanism 124 is a cantilever arm, although other suitable polarization arrangements may be used. The engaging member 128 is a projection that extends radially out of the patient connector 122, although other suitable projections can be used. Hitch member 128 is configured to engage a portion of housing 16 of syringe adapter 120 to polarize hitch member 128 radially inward via the cantilever arm during insertion of patient connector 122 into syringe adapter 120. The latch member 128 is also configured to return to an unpolarized position when patient connector 122 has been fully inserted into syringe adapter 120 to secure patient connector 122 to syringe adapter 120. Consequently, by inserting the patient connector 122 in the housing 16 of the syringe adapter 120, the tilt member 126 is deflected radially inwardly by engaging the latch member 128 with the housing 16 of the syringe adapter 120. Once fully inserted, the tilt member 126 returns to the non-polarized position with the coupling member 128 that holds the connector
    Petition 870190077185, of 08/09/2019, p. 21/41
    17/20 patient 122 on syringe adapter 120 with clamp 32 engaged with clamp 110 interface of patient connector 122. To remove patient connector 122, a user applies axial force to patient connector 122 in a direction away from the syringe adapter 120 so that the tilt member 126 is deflected back radially inwardly by engaging the engagement member 128 with the housing 16 of the syringe adapter 120 until the engagement member 128 is axially displaced in addition to the housing 16 of the syringe adapter 120. The clamp 32 will also be released from the patient connector 122 in the same manner as discussed above in connection with a syringe adapter 12.
    [0080] With reference to FIGS. 21 and 23, syringe adapter 120 can also include a clamp drive member 132 configured to bias clamp 32 towards the second end 20 of syringe adapter 120 to hold clamp 32 in the first position . The syringe adapter 120 operates in the same manner as discussed above in connection with a syringe adapter 12, but the clamp drive member 132 requires a user to overcome the polarization force of the clamp drive member 132 to move the clamp 32 from the first position to the second position when the syringe adapter 120 is matched with a corresponding connector, such as patient connector 122. The clamp drive member 132 can be a spring, although other arrangements suitable polarizing devices can be used. Additionally, as shown in FIGS. 21 to 23, the clamp 32 may not include the first countersink 68 with the first end 54 of the clamp defining a flat surface 134.
    [0081] With reference to FIGS. 25 to 29, a syringe adapter 150 and patient connector 152, according to a further aspect of the present invention, are shown. The syringe adapter 150 is similar to the syringe adapter 12 shown in FIG. 1 and operates from
    Petition 870190077185, of 08/09/2019, p. 22/41
    18/20 in a similar way. The syringe adapter 150 and the patient connector 152 of FIGS. 25 to 29, however, include a different connection arrangement. In particular, instead of providing the first and second connection interfaces 36, 70, patient connector 152 includes a connection member 154. Connection member 154 is configured to engage a portion of housing 16 of syringe adapter 150 to attach patient connector 152 to syringe adapter 150 when patient connector 152 is received by syringe adapter 150. Although connection member 154 is shown with patient connector 152, connection member 154 can be supplied in any suitable component of a system for closed fluid transfer, including, but not limited to, bottle adapters, infusion adapters, etc.
    [0082] Connecting member 154 is a projection extending radially outwardly from patient connector 152. Connecting member 154 is received by a recessed portion 156 of housing 16 of syringe adapter 150 to secure the connector of patient 152 on syringe adapter 150 when patient connector 152 is received by syringe adapter 150. Connecting member 154 is semi-spherical, although other suitable shapes and configurations can be used. As shown in FIG. 28, three equally spaced connection members 154 are provided at patient connector 152, although one or more connection members 154 may be provided. By inserting the patient connector 152 into the housing 16 of the syringe adapter 150, the second membrane 94 of the patient connector 152 engages the first membrane 34 of the clamp 32 and moves the clamp 32 to the second position as described above in connection with a syringe adapter 12. As shown in FIGS. 27 and 29, however, when the clamp 32 is moved to the second position, the connecting member (or members) 154 engages the housing 16 of the syringe adapter 150 and is received within the recessed portion 156 of the housing 16 for additionally attach patient connector 152 to syringe adapter 150. To
    Petition 870190077185, of 08/09/2019, p. 23/41
    19/20 remove the patient connector 152, a user applies an axial force to the patient connector 152 in a direction away from the syringe adapter 150 so that the connecting member (or members) 154 exits the recessed portion 156 of the housing 16 from the syringe adapter 150. The clamp 32 will also be released from the patient connector 152 in the same manner as discussed above.
    [0083] With reference to FIGS. 30 to 35, a syringe adapter 170 and patient connector 172, according to a further aspect of the present invention, are shown. The syringe adapter 170 is similar to the syringe adapter 12 shown in FIG. 1 and operates in a similar way. The syringe adapter 170 of FIGS. 25 to 29, however, includes a different connection arrangement. The syringe adapter 170 includes a movable locking mechanism 174 between an unlocked position (shown in FIGS. 31 and 32) and a locked position (shown in FIGS. 33 and 34). The clamp 32 includes a latch interface 174 which is configured to engage the latch mechanism 174 when the clamp 32 is in the second position and when the latch mechanism 174 is in the locked position. The lock mechanism 174 is disengaged from the lock interface 176 when the clamp 32 is in the second position and when the lock mechanism 174 is in the unlocked position. The locking mechanism 174 is manually movable between the locked and unlocked positions by a user, although other suitable arrangements can be used.
    [0084] The lock mechanism 174 has a first end 178 and a second end 180 and defines an opening 182 that is configured to receive the clamp 32. When the lock mechanism 174 is in the unlocked position, the first end 178 of the locking mechanism 174 protrudes from housing 16 and the second end 180 of locking mechanism 174 is received into housing 16. When locking mechanism 174 is in the locked position, the first end 178 of locking mechanism 174 is received into the housing housing 16 and the second
    Petition 870190077185, of 08/09/2019, p. 24/41
    20/20 end 180 of the locking mechanism 174 protrudes from the housing
    16. The second end 180 of the locking mechanism includes an indicator 184. Indicator 184 may be a colored portion of the locking mechanism 174 that is different from the remaining portion of the locking mechanism 174. The colored portion may be a dominant color, such as red. The locking mechanism 174 is received within the transverse opening 40 of the housing 16 of the syringe adapter 170 and is retained within the housing 16 by means of retaining portions 186 of the locking mechanism 174 positioned intermediate at the first and second ends 178,180 of the locking mechanism. lock 174 that engages the housing 16.
    [0085] As shown in FIG. 32, when the patient connector 172 is received inside the syringe adapter 170 with the clamp 32 moved to the second position, the clamp 32 is received by the opening 182 of the locking mechanism 174. To maintain the clamp clamp 32 and the patient connector 172 in the second position, the locking mechanism 174 is moved to the locked position so that the locking mechanism 174 engages the locking interface 176 of the clamp 32 with the indicator 184 which provides an indication of the locked state of syringe adapter 170.
    [0086] Although this revelation has been described as having exemplary designs, the present revelation can be further modified within the spirit and scope of this revelation. This request is therefore intended to cover any variations, uses or adaptations of the disclosure with the use of its general principles. In addition, this application is intended to cover such deviations from the present disclosure as they arise within known or common practice in the technique to which this disclosure belongs and which fall within the limits of the appended claims.
    权利要求:
    Claims (16)
    [1]
    1. Syringe adapter characterized by comprising: a housing having a first end and a second end, the first end configured to be attached to a first container;
    a cannula having a first end and a second end, the second end of the cannula being positioned within the housing; and a clamp having a first end and a second end, at least a portion of the clamp received within the housing, the clamp comprising a body defining a passage, a membrane received by the passage and a connected locking member to the body of the clamp, the membrane comprising a body having a first end and a second end, the clamp is movable from a first position where the locking member is opened to receive a matching connector for a second position in which movement radially outward from the locking member is restricted, where the passage of the body of the clamp comprises a narrowed portion configured to compress a portion of the membrane body.
    [2]
    2. Syringe adapter according to claim 1, characterized in that the passage of the body of the clamp comprises a first reamer, a second reamer positioned opposite the first reamer, and an intermediate portion, the intermediate portion of the passage of the clamp body including the narrowed portion.
    [3]
    Syringe adapter according to claim 2, characterized in that the narrowed portion of the passage has a smaller diameter than a remainder of the intermediate portion of the passage.
    Petition 870190067051, of 07/16/2019, p. 68/71
    2/3
    [4]
    4. Syringe adapter according to claim 3, characterized in that the membrane has a first head portion and a second head portion, the first and second head portions extending radially outwardly from the body of the membrane, the membrane body having a first portion having a first diameter and a second portion having a second diameter, the first diameter smaller than the second diameter.
    [5]
    5. Syringe adapter according to claim 4, characterized in that the intermediate portion of the passage of the body of the clamp receives the first portion of the membrane.
    [6]
    6. Syringe adapter according to claim 5, characterized in that the second countersink in the passage of the body of the clamp receives the second portion of the membrane.
    [7]
    7. Syringe adapter according to claim 1, characterized by the fact that the membrane body defines a passage.
    [8]
    Syringe adapter according to claim 7, characterized in that the passage of the membrane extends from the first end of the membrane body towards the second end of the membrane body.
    [9]
    9. Syringe adapter according to claim 8, characterized in that the passage of the membrane ends in an intermediate position at the first and second ends of the membrane body.
    [10]
    Syringe adapter according to claim 2, characterized in that the membrane includes a first head portion and a second head portion.
    [11]
    Syringe adapter according to claim 10, characterized in that the first head portion of the membrane is positioned within the passage of the clamp, and the second head portion is engaged with one end of the body of the clamp.
    Petition 870190067051, of 07/16/2019, p. 69/71
    3/3
    [12]
    Syringe adapter according to claim 10, characterized in that the first head portion includes a frustoconical surface.
    [13]
    13. Syringe adapter according to claim 12, characterized in that the second head portion includes a convex surface.
    [14]
    14. Syringe adapter according to claim 10, characterized by the fact that the first portion of the membrane head engages the clamp and is positioned inside the first countersink.
    [15]
    15. Syringe adapter according to claim 1, characterized in that the clamp passage has a first portion and a second portion, the first portion of the passage including the narrowed portion.
    [16]
    16. Syringe adapter according to claim 15, characterized in that the first portion of the clamp passage has a smaller diameter than the second portion of the clamp passage.
    类似技术:
    公开号 | 公开日 | 专利标题
    BR112019014626A2|2020-04-14|syringe adapter for closed fluid transfer
    BR112019014739A2|2020-03-03|SYRINGE ADAPTER WITH LOCKING MECHANISM
    BR112019014698A2|2020-02-18|CONNECTOR FOR CLOSED FLUID TRANSFER SYSTEM
    ES2689083T3|2018-11-08|Syringe adapter with combined decoupling movement
    ES2763163T3|2020-05-27|Fluid communication connector
    US10850087B2|2020-12-01|Fluid transfer device and packaging therefor
    ES2806132T3|2021-02-16|System for closed fluid transfer with a connector
    ES2808904T3|2021-03-02|System for closed fluid transfer and membrane devices for its use
    AU2016276956B2|2018-08-09|Syringe adapter with spinning connector
    JP2013526398A|2013-06-24|Connector, fluid container
    BR112016024683B1|2021-12-21|SYRINGE ADAPTER WITH COMPOUND MOTION DISENGAGEMENT AND METHOD
    BR112016024680B1|2021-10-19|SYRINGE ADAPTER
    BR112020014575A2|2020-12-01|detachable medical tube connector
    同族专利:
    公开号 | 公开日
    AU2018210218A1|2019-08-15|
    CN208927071U|2019-06-04|
    CN108324565A|2018-07-27|
    EP3570807A1|2019-11-27|
    IL268042D0|2019-09-26|
    US20180200147A1|2018-07-19|
    JP2020503979A|2020-02-06|
    WO2018136361A1|2018-07-26|
    CA3050461A1|2018-07-26|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US8287513B2|2007-09-11|2012-10-16|Carmel Pharma Ab|Piercing member protection device|
    US20130076019A1|2010-06-30|2013-03-28|Terumo Kabushiki Kaisha|Connector and connector assembly|
    JP6356828B2|2014-04-21|2018-07-11|ベクトン ディキンソン アンド カンパニー リミテッド|Fluid transfer device and packaging therefor|
    CN106470657B|2014-04-21|2020-03-17|贝克顿迪金森有限公司|System for closed transfer of fluids|
    AU2015249947B9|2014-04-21|2017-11-30|Becton Dickinson and Company Limited|System for closed transfer of fluids and membrane arrangements for use thereof|
    US10561802B2|2015-06-12|2020-02-18|Becton Dickinson and Company Limited|Syringe adapter with spinning connector|
    WO2018136361A1|2017-01-17|2018-07-26|Becton Dickinson and Company Limited|Syringe adapter for closed transfer of fluids|WO2018136361A1|2017-01-17|2018-07-26|Becton Dickinson and Company Limited|Syringe adapter for closed transfer of fluids|
    USD877900S1|2018-04-04|2020-03-10|Becton Dickinson and Company Limited|Medical infusion adapter|
    USD873996S1|2018-04-04|2020-01-28|Becton Dickinson and Company Limited|Medical syringe adapter|
    USD908872S1|2018-04-04|2021-01-26|Becton Dickinson and Company Limited|Medical vial access device|
    USD888945S1|2018-04-04|2020-06-30|Becton Dickinson and Company Limited|Medical connector|
    CA3103105A1|2018-07-31|2020-02-06|Amgen Inc.|Fluid path assembly for a drug delivery device|
    USD896372S1|2019-06-27|2020-09-15|Karl Storz Endovision, Inc.|Connector for medical device|
    US10945922B1|2019-09-26|2021-03-16|Abyssal Systems, Inc.|Apparatus for creating a sealed conduit between separate volumes|
    US20210228446A1|2020-01-09|2021-07-29|Becton, Dickinson And Company|Drug Transfer Device|
    DE102020203153A1|2020-03-11|2021-09-16|B. Braun Melsungen Aktiengesellschaft|Coupling element for a closed fluid transfer system, attachment for such a coupling element, coupling system and coupling kit|
    CN112336422B|2020-10-20|2021-11-30|成都尚古医疗器械有限公司|Puncture kit and puncture device|
    法律状态:
    2021-10-19| B350| Update of information on the portal [chapter 15.35 patent gazette]|
    优先权:
    申请号 | 申请日 | 专利标题
    US201762447038P| true| 2017-01-17|2017-01-17|
    PCT/US2018/013720|WO2018136361A1|2017-01-17|2018-01-15|Syringe adapter for closed transfer of fluids|
    [返回顶部]